Ocular Therapeutix™ Announces Submission to the FDA of a Supplemental New Drug Application …,

The safety of DEXTENZA was assessed in three Phase 3 clinical trials and a Phase 2 clinical trial evaluating DEXTENZA for the treatment of post- …, The safety of DEXTENZA was assessed in three Phase 3 clinical trials and a Phase 2 clinical trial evaluating DEXTENZA for the treatment of post- …, Read More

Scroll to Top